Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke

Thrombosis Research

Volumn 112, Issue 5-6, 2003, Pages 275-283

  Hillarp, Andreas ^a   Palmqvist, Barbro ^a   Lethagen, Stefan ^a   Villoutreix, Bruno O ^a   Mattiasson, Ingrid ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood platelets; Cerebral stroke; Cyclooxygenase; Mutation; Platelet aggregation; Protein structure

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; COLLAGEN; CYCLOOXYGENASE 1;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CATALYSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 1642309585     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.12.005     Document Type: Article

References (25)

1. Smith N.M., Pathansali R., Bath P.M. Platelets and stroke. Vasc. Med. 4:1999;165-172.
2. Roth G.J., Majerus P.W. The mechanism of the effect of aspirin on human platelets: I. Acetylation of a particulate fraction of the protein. J. Clin. Invest. 56:1975;624-632.
3. Lecomte M., Laneuville O., Ji C., DeWitt D.L., Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 269:1994;13207-13215.
4. Yokoyama C., Tanabe T. Cloning of the human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem. Biophys. Res. Commun. 165:1989;888-894.
5. Funk C.D., Funk L.B., Kennedy M.E., Pong A.S., Fitzgerald G.A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment. FASEB J. 5:1991;2304-2312.
6. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. U. S. A. 89:1992;7384-7388.
7. Jones D.A., Carlton D.P., McIntyre T.M., Zimmerman G.A., Prescott S.M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268:1993;9049-9054.
8. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S.et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. U. S. A. 99:2002;13926-13931.
9. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:2000;145-182.
10. Otto J.C., Smith W.L. The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmatic reticulum. J. Biol. Chem. 269:1994;19868-19875.
11. Grotemeyer K.-H. Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients. Thromb. Res. 63:1991;587-593.
12. Grotemeyer K.-H., Scharafinski H.-W., Husstedt I.-W. Two-year follow up of aspirin responder and aspirin non responder. A pilot study including 180 post-stroke patients. Thromb. Res. 71:1993;397-403.
13. Helgason C.M., Tortorice K.L., Winkler S.D., Penney D.W., Schuler J.J., McClelland T.J., Brace L.D. Aspirin response and failure in cerebral infarction. Stroke. 24:1993;345-350.
14. Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J. Thromb. Haemost. 1:2003;1710-1713.
15. De Gaetano G., Cerletti C. Aspirin resistance: a revival of platelet aggregation tests. J. Thromb. Haemost. 1:2003;2048-2050.
16. Scott B.T., Hasstedt S.J., Bovill E.G., Callas P.W., Valliere J.E., Wang L.et al. Characterization of the human prostaglandin H synthase 1 gene (PTGS1): exclusion by genetic linkage analysis as a second modifier gene in familial thrombosis. Blood Coagul. Fibrinolysis. 13:2002;519-531.
17. Cambria-Kiely J.A., Gandhi P.J. Aspirin resistance and genetic polymorphisms. J. Thromb. Thrombolysis. 14:2002;51-58.
18. Halushka M.K., Walker L.P., Halushka P.V. Genetic variation in cyclooxygenase: 1. Effects on response to aspirin. Clin. Pharmacol. Ther. 73:2003;122-130.
19. 2 synthase. Nature. 367:1994;243-249.
20. 2 synthase. Nat. Struct. Biol. 2:1995;637-643.
21. Malkowski M.G., Ginell S.L., Smith W.L., Garavito R.M. The productive conformation of arachidonic acid bound to prostaglandin synthase. Science. 289:2000;1933-1937.
22. 2 synthase-1 to the surface of a phospholipid bilayer. Eur. Biophys. J. 29:2000;439-454.
23. 523→Val mutation. J. Biol. Chem. 272:1997;9280-9286.
24. Eikelboom J.W., Hankey G.J. Aspirin resistance: a new independent predictor of vascular events. J. Am. Coll. Cardiol. 41:2003;966-968.
25. Hillarp A., Lethagen S., Mattiasson I. Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity. J. Thromb. Haemost. 1:2003;196-197.